Clínica Baviera, S.A. (FRA:D9Z)

Market Cap	858.25M +66.2%
Revenue (ttm)	296.76M +17.5%
Net Income	40.48M +9.2%
EPS	2.53 +9.0%
Shares Out	n/a
PE Ratio	21.20
Forward PE	n/a
Dividend	1.27 (2.44%)
Ex-Dividend Date	Jun 11, 2025

Volume	n/a
Average Volume	53
Open	51.80
Previous Close	52.40
Day's Range	51.80 - 51.80
52-Week Range	29.80 - 52.60
Beta	n/a
RSI	68.88
Earnings Date	Feb 26, 2026

About Clínica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and chang...

• Industry: Health Services
• Founded: 1992
• Employees: 1,847
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: D9Z

Financial Performance

In 2024, Clínica Baviera's revenue was 265.72 million, an increase of 17.02% compared to the previous year's 227.07 million. Earnings were 40.21 million, an increase of 11.77%.